Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 10.96 CHF -1.08% Market Closed
Market Cap: 452.2m CHF

Intrinsic Value

The intrinsic value of one MEDX stock under the Base Case scenario is 14.23 CHF. Compared to the current market price of 10.96 CHF, Medmix Ltd is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEDX Intrinsic Value
14.23 CHF
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medmix Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MEDX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MEDX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MEDX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Medmix Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medmix Ltd

Current Assets 261.2m
Cash & Short-Term Investments 118.1m
Receivables 65.7m
Other Current Assets 77.4m
Non-Current Assets 693m
Long-Term Investments 8m
PP&E 262m
Intangibles 388.8m
Other Non-Current Assets 34.2m
Efficiency

Free Cash Flow Analysis
Medmix Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medmix Ltd

Revenue
483.9m CHF
Cost of Revenue
-324.2m CHF
Gross Profit
159.7m CHF
Operating Expenses
-140.9m CHF
Operating Income
18.8m CHF
Other Expenses
-26.2m CHF
Net Income
-7.4m CHF
Fundamental Scores

MEDX Profitability Score
Profitability Due Diligence

Medmix Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
45/100
Profitability
Score

Medmix Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

MEDX Solvency Score
Solvency Due Diligence

Medmix Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
40/100
Solvency
Score

Medmix Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDX Price Targets Summary
Medmix Ltd

Wall Street analysts forecast MEDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDX is 22.95 CHF with a low forecast of 20.2 CHF and a high forecast of 26.25 CHF.

Lowest
Price Target
20.2 CHF
84% Upside
Average
Price Target
22.95 CHF
109% Upside
Highest
Price Target
26.25 CHF
140% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MEDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MEDX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MEDX stock?

The intrinsic value of one MEDX stock under the Base Case scenario is 14.23 CHF.

Is MEDX stock undervalued or overvalued?

Compared to the current market price of 10.96 CHF, Medmix Ltd is Undervalued by 23%.

Back to Top